证券代码：688625 证券简称：呈和科技 公告编号：2025-033 呈和科技股份有限公司 2025年中期权益分派实施公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 每股现金红利0.23元 相关日期 | 股权登记日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | | 2025/9/2 | 2025/9/3 | 2025/9/3 | 一、 通过分配方案的股东大会届次和日期 本次利润分配方案经呈和科技股份有限公司（以下简称"公司"）2025 年 5 月 20 日召 开的2024年年度股东大会审议通过授权董事会制定实施，并经公司第三届董事会第十一次会 议审议通过。 二、 分配方案 1. 发放年度：2025年中期 2. 分派对象： 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任公司上海分 公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 根据《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第 7 号——回 购股份》等相关规定，上 ...

中信证券股份有限公司 关于呈和科技股份有限公司差异化分红事项的核查意见 中信证券股份有限公司（以下简称"中信证券"、"保荐人"）作为呈和科 技股份有限公司（以下简称"呈和科技"、"公司"）以简易程序向特定对象发 行 A 股股票的保荐人，根据《中华人民共和国公司法》（以下简称"《公司法》"） 《中华人民共和国证券法》（以下简称"《证券法》"）《证券发行上市保荐业 务管理办法》《上海证券交易所上市公司自律监管指引第 7 号——回购股份》《上 海证券交易所上市公司自律监管指引第 11 号——持续督导》等有关法规和规范 性文件的要求，对呈和科技 2025 年中期利润分配方案所涉及的差异化权益分派 方案（以下简称"本次差异化分红"）事项进行了核查，具体情况如下： 一、本次差异化分红的原因 公司分别于 2023 年 10 月 26 日、2023 年 11 月 14 日召开了第三届董事会第 二次会议、2023 年第三次临时股东大会，审议通过了《关于以集中竞价交易方 式回购公司股份方案的议案》，同意公司使用自有资金通过上海证券交易所交易 系统以集中竞价交易方式回购公司股份，回购股份将在未来适宜时机用于股权激 励及/或员工持股 ...

证券代码：688625 证券简称：呈和科技 公告编号：2025-033 呈和科技股份有限公司 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ? 是否涉及差异化分红送转：是 ? 每股分配比例 每股现金红利0.23元 ? 相关日期 股权登记日 除权（息）日 现金红利发放日 一、 通过分配方案的股东大会届次和日期 本次利润分配方案经呈和科技股份有限公司（以下简称"公司"）2025 年 5 月 20 日召 开的2024年年度股东大会审议通过授权董事会制定实施，并经公司第三届董事会第十一次会 议审议通过。 二、 分配方案 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任公司上海分 公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 根据《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第 7 号——回 购股份》等相关规定，上市公司回购专用证券账户中的股份不享有股东大会表决权、利润分 配、公积金转增股本、认购新股等权利。因此，公司通过回购专用证券账户所持有的本公司 股份，不参与 ...

Group 1: Resident Deposit Migration - The report indicates that resident deposit migration is expected to begin, typically occurring 10-12 months after a market transition from bear to bull, with the current period being 11 months since the last transition [1][6][7] - Initial signs of deposit migration have emerged, with a notable increase in non-bank deposit growth turning positive, suggesting potential for significant market inflow [6][9] - Short-term market consolidation of 2-3 months is anticipated as deposits begin to migrate, based on historical patterns observed in previous bull markets [8][9] Group 2: Unmanned Sanitation Vehicles - The unmanned sanitation vehicle market is projected to reach a scale of approximately 123 billion yuan in 2024, with significant growth expected as the industry transitions from the 0-1 stage to mass production [12][14] - The economic benefits of unmanned sanitation vehicles are substantial, with potential labor cost savings of 12-16 million yuan per vehicle by replacing 3-4 workers, leading to a cost reduction of up to 66% under certain conditions [13][15] - The market for unmanned sanitation vehicles is estimated to be worth between 1.16 trillion and 2.91 trillion yuan, depending on the replacement rate of sanitation workers [14][15] Group 3: Semiconductor Equipment - The report highlights a significant growth potential in the semiconductor equipment sector, particularly in the context of domestic AI development and the need for self-sufficient supply chains [3][18] - The domestic semiconductor equipment market has an average annual scale of approximately 41.7 billion USD, with expectations for continued expansion driven by AI applications [19] - Key companies in the semiconductor equipment space are recommended for investment, including those involved in front-end and back-end equipment, as well as the photolithography supply chain [19] Group 4: Power Prediction Business - The company is recognized as a leader in power prediction, with a projected net profit growth of 40% to 27% from 2025 to 2027, supported by a strong market demand and technological barriers [4][22][24] - The number of service sites for power prediction has increased significantly, indicating robust growth in this segment, with a 55.14% increase in revenue from power prediction services [23] - The company is actively investing in strategic partnerships to enhance its market position in the renewable energy sector [24] Group 5: Wind Power Equipment - The company has reported a 41.26% increase in revenue for the first half of 2025, driven by a significant rise in wind turbine sales, which saw a 106.58% increase in sales capacity [32][33] - The company’s gross margin for wind turbine sales has improved, reflecting operational efficiencies and increased demand [33] - Future projections indicate continued growth in net profit, with expectations of 63.8% growth from 2025 to 2027 [35] Group 6: Lithium Battery Materials - The company has achieved a 28.97% increase in revenue for the first half of 2025, with expectations for further price stabilization and growth in the second half of the year [37][38] - The company is focusing on innovation in lithium battery materials, with significant investments in new technologies and production capabilities [38][39] - Projections for net profit growth from 2025 to 2027 are robust, with an anticipated increase of 68.5% [39]

Group 1 - The core viewpoint of the report is that Chenghe Technology (688625.SH) is rated as a buy due to its stable performance and significant growth in overseas business [2] - The modified plastic industry has substantial development potential, and the nucleating agent sector is at a critical stage of domestic substitution [2] - The main products of the company have the capability for import substitution and possess advanced patented technology [2]

Investment Rating - The report maintains a "Buy-B" rating for the company [5] Core Views - The company achieved steady revenue growth in the first half of 2025, with total revenue of 471 million yuan, up 13.77% year-on-year, and a net profit of 147 million yuan, up 15.33% year-on-year [1][2] - The company is actively seizing market opportunities, accelerating product innovation, and expanding its application downstream, which has led to increased market share and steady performance growth [2] - The modified plastics industry has significant growth potential, and the nucleating agent sector is at a critical stage of domestic substitution, with the company positioned to lead in high-performance nucleating agents [3][4] Financial Performance - In the first half of 2025, the nucleating agent segment generated 297 million yuan in revenue, while synthetic talc, NDO composite additives, and antioxidants contributed 63 million yuan, 31 million yuan, and 38 million yuan, respectively [2] - The company's overseas revenue reached 120 million yuan, indicating strong international market performance [2] - The gross margin for the first half of 2025 was 45.79%, an increase of 0.7 percentage points year-on-year, while the expense ratio was 10.46%, up 1.63 percentage points year-on-year [2] Industry Outlook - From 2019 to 2023, China's modified plastics production increased from 19.55 million tons to 29.75 million tons, with a compound annual growth rate of 11.07%, indicating a robust growth trajectory for the industry [3] - The high-end modified plastics market in China still relies heavily on imports, and the industry is currently at a pivotal point for domestic substitution [3] Investment Projections - The projected net profits for 2025, 2026, and 2027 are 277 million yuan, 336 million yuan, and 380 million yuan, respectively, with corresponding price-to-earnings ratios of 23.2, 19.2, and 17 times [5][9]

Investment Rating - The report provides a standard investment rating for the chemical industry, indicating a positive outlook for specific sectors within the industry [5]. Core Insights - The report highlights the impact of the explosion at Kanto Denka's facility in Japan, which is expected to create opportunities for domestic electronic gas suppliers as Kanto Denka holds a 90% market share in nitrogen trifluoride production in Japan [6][13]. - The first World Humanoid Robot Games held in Beijing is seen as a catalyst for the robotics industry's development, showcasing technological innovation and attracting talent [6][14]. - The report emphasizes the structural optimization of supply in the chemical sector, suggesting a focus on sectors with significant elasticity and competitive advantages, such as organic silicon and membrane materials [6][15]. Industry Performance - The report notes that during the week of August 11 to August 15, 2025, the CSI 300 index rose by 2.37%, while the Shenwan Basic Chemical Index increased by 2.46%, outperforming the market slightly [6][18]. - The top-performing sub-sectors included modified plastics (up 12.29%) and fluorochemicals (up 5.81%), while the worst performers were civil explosives (down 3.02%) and compound fertilizers (down 1.81%) [6][19]. Price Trends - Key products that saw price increases included hydrochloric acid (up 15.38%) and propylene (up 4.00%), while notable declines were observed in butanone (down 7.16%) and liquid ammonia (down 5.89%) [6][26]. - The report tracks price differentials, with significant increases in the propylene-propane differential (up 33.47%) and decreases in the bisphenol A-phenol differential (down 26.57%) [6][28]. Investment Recommendations - The report suggests focusing on sectors that may benefit from supply-side reforms, particularly organic silicon, membrane materials, and dye sectors, with recommended companies including Hoshine Silicon Industry and Zhejiang Longsheng [6][15]. - It also highlights the growing demand for health additives and sugar substitutes driven by new consumer trends, recommending companies that emphasize technological and product differentiation [6][16][17].

Investment Rating - The report maintains an "Outperform" rating for the company, indicating a positive outlook for its performance relative to the market [1]. Core Views - The company's performance in 2025 is expected to show significant growth in production and sales, driven by a strong trend of domestic substitution [1][3]. - The company achieved a revenue of 471 million yuan in the first half of 2025, reflecting a year-on-year growth of 13.77%, and a net profit of 147 million yuan, up 15.33% year-on-year [3]. - The report highlights the acceleration of domestic production due to increased overseas trade disruptions, which is expected to enhance the domestic substitution process [3]. - The company is focusing on both organic growth and potential acquisitions to support its performance expansion, with a new production capacity of 28,900 tons coming online [3]. Financial Data and Profit Forecast - The projected total revenue for 2025 is 1,075 million yuan, with a year-on-year growth rate of 21.9% [2]. - The forecasted net profit for 2025 is 311 million yuan, representing a 24.2% increase compared to the previous year [2]. - The earnings per share (EPS) for 2025 is estimated at 1.65 yuan, with a gross margin of 47.3% [2]. - The return on equity (ROE) is expected to be 19.4% in 2025 [2]. Market Position and Competitive Landscape - The company is positioned to benefit from the high demand in downstream industries such as PP and PVC, which are experiencing significant growth [3]. - The report notes that the company has successfully broken the technical monopoly of international brands in the nucleating agent sector, with its products meeting international standards [3]. - The company is actively seeking acquisition opportunities that align with its strategic development to enhance its competitive edge [3].

Investment Rating - The investment rating for the company is "Buy" and it is maintained [10] Core Views - The company achieved a revenue of 471 million yuan in the first half of 2025, representing a year-on-year increase of 13.8%, and a net profit attributable to shareholders of 147 million yuan, up 15.3% year-on-year [2][7] - In Q2 alone, the company generated a revenue of 251 million yuan, which is a 12.7% increase year-on-year and a 14.0% increase quarter-on-quarter [2][7] - The company's main products, nucleating agents and synthetic hydrotalcite, are key raw materials for producing high-performance resins, and the domestic substitution is accelerating amid global trade policy fluctuations [13] - The company has completed its IPO project and fully utilized its Nansha plant, enhancing its production capacity significantly [13] - The overseas revenue reached 120 million yuan in the first half of 2025, marking a substantial growth of 70.1% year-on-year, indicating a strong international strategy [13] - The company aims to become a "definer" of comprehensive solutions in high polymer materials, enhancing customer satisfaction and loyalty through customized services [13] - The company is a leader in the domestic nucleating agent and synthetic hydrotalcite market, with potential for continued market share growth [13] Financial Summary - The company forecasts net profits of 297 million yuan, 348 million yuan, and 401 million yuan for the years 2025, 2026, and 2027 respectively [13] - The total revenue is projected to reach 1.058 billion yuan in 2025, with a gross profit margin of 44% [19] - The company’s net profit margin is expected to be around 28.1% in 2025 [19]

Core Viewpoint - The company reported a steady growth in revenue and net profit for the first half of 2025, driven by market opportunities and product innovation [1][2]. Financial Performance - In the first half of 2025, the company achieved revenue of 471.08 million yuan, a year-on-year increase of 13.77% [2] - The net profit attributable to shareholders was 147.25 million yuan, reflecting a year-on-year growth of 15.33% [2] - In Q2 2025, revenue reached 251 million yuan, up 12.75% year-on-year, with net profit of 75.78 million yuan, increasing by 14.86% [1][2] Market Position and Strategy - The company is benefiting from the ongoing US-China trade disputes, with a continuous increase in market share for its polymer material additives [3] - The company has maintained double-digit growth for ten consecutive years, with a focus on forward-looking R&D and customized solutions to meet customer needs [3] - The company has over 180 different types of nucleating agents, synthetic hydrotalcite, and composite additives in large-scale production, enhancing its ability to provide one-stop raw material supply to high-quality customers [3] Future Outlook - The company is expected to maintain strong revenue growth, with projected revenues of 1.138 billion yuan, 1.388 billion yuan, and 1.721 billion yuan for 2025-2027 [4] - Net profits are forecasted to be 295 million yuan, 334 million yuan, and 411 million yuan for the same period [4] - The current stock price corresponds to a PE ratio of 22.1, 19.5, and 15.8 for the years 2025, 2026, and 2027 respectively [4]